Publicaciones en colaboración con investigadores/as de Pfizer (United States) (14)

2024

  1. Effect of long-term tafamidis treatment on health-related quality of life in patients with transthyretin amyloid cardiomyopathy

    European Journal of Heart Failure, Vol. 26, Núm. 3, pp. 612-615

  2. The effect of long-term tafamidis treatment on quality of life in people with transthyretin amyloid cardiomyopathy (ATTR-CM): A plain language summary

    Future Cardiology

2023

  1. Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV Trial

    Journal of Rheumatology, Vol. 50, Núm. 4, pp. 478-487

2022

  1. Response to: 'Use of tanezumab for patients with hip and knee osteoarthritis with reference to a randomised clinical trial by Berenbaum and colleagues' by Riddle and Perera

    Annals of the Rheumatic Diseases

2021

  1. Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?

    European Journal of Pain (United Kingdom), Vol. 25, Núm. 7, pp. 1525-1539

2020

  1. Cost-effectiveness analysis of second-line pharmacological treatment of acromegaly in Spain

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 20, Núm. 1, pp. 105-114

  2. Gender differences in health-related quality of life in patients with systolic heart failure: Results of the vida multicenter study

    Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-15

  3. Subcutaneous tanezumab for osteoarthritis of the hip or knee: Efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 6, pp. 800-810

2019

  1. Treatment adherence to pegvisomant in patients with acromegaly in Spain: PEGASO study

    Pituitary, Vol. 22, Núm. 2, pp. 137-145

2014

  1. Assessment of osteoarthritis candidate genes in a meta-analysis of nine genome-wide association studies

    Arthritis and Rheumatology, Vol. 66, Núm. 4, pp. 940-949

  2. Sirolimus conversion after heart transplant: Risk factors for acute rejection and predictors of renal function response

    American Journal of Transplantation, Vol. 14, Núm. 9, pp. 2048-2054

2012

  1. Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency

    American Journal of Transplantation, Vol. 12, Núm. 9, pp. 2487-2497

2009

  1. Biology of BMP signalling and cancer

    Clinical and Translational Oncology, Vol. 11, Núm. 3, pp. 126-137

  2. Notch signalling in cancer stem cells

    Clinical and Translational Oncology, Vol. 11, Núm. 1, pp. 11-19